Click to see our news releases about special projects and other announcements.Read More
Journalists: We are at your service. Please contact us with your request.Connect
Between 2018 and 2020, Amy Zamora’s tenure as a systems research scholar allowed her to merge her two interests – math and biology – and to learn a lot more along the way. “I didn’t really know how to combine my passions until I came to ISB,” she said.
In ISB’s first-ever Research Roundtable event, Assistant Professor Dr. Sean Gibbons delivered a presentation titled “Gut-Check: Personalized Nutrition and Your Microbiome.” His talk covered a lot of ground, including recently published research showing how the health of our microbiomes can predict longevity, and how we can build and maintain a healthy gut microbiome.
To advance research at the intersection of COVID-19 and cancer, The Andy Hill CARE Fund has awarded ISB Assistant Professor Dr. Wei Wei a $100,000 grant to study chronic lymphocytic leukemia (CLL), one of the most commonly diagnosed leukemias in the Western world that mainly affects older individuals.
Daniel Chen, an undergraduate researcher in ISB’s Heath Lab and junior at the University of Washington, has been awarded a prestigious Goldwater Scholarship. Chen has been a key member of ISB’s COVID-19 Immune Response Study.
Dr. Naeha Subramanian – an expert in immunology, innate immunity, and host-pathogen interactions, and head of ISB’s Subramanian Lab – has been promoted to Associate Professor. “I am honored with this promotion and excited about the incredible research being conducted in my lab. It is a pleasure and privilege to tackle exciting questions everyday,” she said.
ISB researchers and their collaborators are looking beyond the one-drug, one-solution approach that has thus far failed in Alzheimer’s disease research. Instead, they are focusing on other promising research avenues, such as the possible role of the gut microbiome in dementia.
ISB researchers examined the associations between the gut microbiomes of about 3,400 people and roughly 150 host characteristics. The team looked at diet, medication use, clinical blood markers, and other lifestyle and clinical factors, and found evidence that variations of the gut microbiome are associated with health and disease.
Dr. Nathan Price has been inducted into the American Institute for Medical and Biological Engineering’s (AIMBE) College of Fellows. Price was nominated, reviewed, and elected by peers and members of the College of Fellows for his contributions deriving medical and biological insights from large-scale data analysis and network modeling, and translating those insights to society.
The National Academy of Medicine (NAM) announced ISB’s Dr. Nathan Price as a 2019 Emerging Leader in Health and Medicine Scholar. NAM’s Emerging Leaders in Health and Medicine Program provides a platform for a new generation of leaders to collaborate with the NAM and its members across generations and fields of expertise.
The Andy Hill Cancer Research Endowment (CARE) is a public-private partnership that supports cancer research in Washington state. CARE announced ISB Assistant Professor Dr. Wei Wei as a CARE Fund Distinguished Researcher and awarded him $500,000.
In the two decades since joining Dr. Lee Hood as a postdoc, Dr. Qiang Tian has made a tremendous impact on ISB’s science and culture. March 31 is his final day at ISB, as he is returning to China and joining Shanghai’s National Research Center for Translational Medicine.
The human microbiome is a relatively new area of research, and there are numerous questions surrounding it. What is the human microbiome? Can we change it? Does it make us sick? Keep us well? ISB Assistant Professor and microbiome researcher Dr. Sean Gibbons answers these questions — and many more.
Amy Zamora joined ISB in August as a Systems Research Scholar. The Systems Research Scholars Program provides recent college undergraduates a springboard to become the next generation’s pioneers of interdisciplinary scientific research. In this Q&A, Zamora describes her experiences at ISB, research interests, future aspirations, and much more.
The Andy Hill Cancer Research Endowment (CARE) announced $750,000 in grant funding for Dr. Jim Heath’s work on proactive cancer immunotherapies for initial and recurrent disease. This is the first stage of a planned longer program led by Jim and ISB, and involving Swedish Cancer Institute, Earl A. Chiles Research Institute in Portland, and UW Medicine.
Dr. James Yurkovich joined ISB this summer as a Translational Research Fellow. The three-year Translational Research Fellows Program provides a unique opportunity for bench-to-bedside translational research with mentorship from experts in systems biology and clinical research. In this Q&A, Yurkovich delves into his research interests, future aspirations, hobbies, and more.
In 2013, Joo was a high school intern in ISB’s Hood Lab. In 2014, she came back for another internship, this time in the Huang Lab. Joo has since graduated from the University of Washington with a Biochemistry and Molecular, Cellular and Development Biology double major, and now she’s working at Seattle Children’s Research Institute Center for Immunity and Immunotherapies in the Miao Lab.
Prior to joining ISB’s faculty, Dr. Wei Wei earned his Ph.D. from Caltech and served as a faculty member at UCLA Medical School. In this Q&A, Wei discusses his research career to date, how research might change over the next decade, and much more.
The Innovator Award Program at Institute for Systems Biology is an annual internal initiative started in 2017 that aims to stimulate creativity, innovation and collaboration within ISB, to provide funding support for high-risk, high-reward projects, and to develop new technologies and discoveries that will impact the entire research organization.